Literature DB >> 9721013

Modulators of soluble guanylyl cyclase.

D Koesling1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9721013     DOI： 10.1007/pl00005232

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  6 in total

1.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.

Authors:  P Wohlfart; T Malinski; H Ruetten; U Schindler; W Linz; K Schoenafinger; H Strobel; G Wiemer
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Transient relaxation of rat mesenteric microvessels by ceramides.

Authors:  Peter Czyborra; Miriam Saxe; Charlotte Fetscher; Dagmar Meyer Zu Heringdorf; Stefan Herzig; Karl H Jakobs; Martin C Michel; Angela Bischoff
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Modulation of penile erection in rabbits by Mondia whitei: possible mechanism of action.

Authors:  O Quasie; O N K Martey; A K Nyarko; W S K Gbewonyo; L K N Okine
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-04-03

5.  JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.

Authors:  Astrid Weyerbrock; Nadja Osterberg; Nikolaos Psarras; Brunhilde Baumer; Evangelos Kogias; Anna Werres; Stefanie Bette; Joseph E Saavedra; Larry K Keefer; Anna Papazoglou
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

6.  Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo.

Authors:  Marc Oppermann; Vera Balz; Volker Adams; Vu Thao-Vi Dao; Murat Bas; Tatsiana Suvorava; Georg Kojda
Journal:  J Cell Mol Med       Date:  2008-12-24       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.